| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/04/2002 | EP1235936A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1235934A2 Screening method for candidate drugs |
| 09/04/2002 | EP1235910A1 Plant virus particles with exogenous internal eitopes |
| 09/04/2002 | EP1235907A1 6 human secreted proteins |
| 09/04/2002 | EP1235900A1 Microparticle-based transfection and activation of dendritic cells |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235846A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235843A1 26 human secreted proteins |
| 09/04/2002 | EP1235834A1 (1r,cis)-4-(4-amino-7h-pyrr0l0[2,3- i(d)]pyrimidine-7-yl)-2-cyclopentene-1-methanol derivatives as antiviral |
| 09/04/2002 | EP1235833A1 Analogs of (1s, cis)-4-(2-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral |
| 09/04/2002 | EP1235824A1 Vitamin d analogues |
| 09/04/2002 | EP1235815A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 09/04/2002 | EP1235814A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 09/04/2002 | EP1235812A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 09/04/2002 | EP1235618A2 Bioconjugation in vivo to pulmonary or blood components |
| 09/04/2002 | EP1235597A2 Nucleic acid delivery system |
| 09/04/2002 | EP1235596A2 Use of lytic toxins and toxin conjugates |
| 09/04/2002 | EP1235589A2 Compositions comprising neisseria meningitidis antigens from serogroups b and c as well as a further antigen |
| 09/04/2002 | EP1235566A2 Valnemulin formulation |
| 09/04/2002 | EP1080086B1 Dihydropyrimidines |
| 09/04/2002 | EP1068223B1 Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 09/04/2002 | EP1022279B1 New carbapenem derivatives |
| 09/04/2002 | EP0999849B1 Use of lbp in the treatment of septicaemia |
| 09/04/2002 | EP0913151B1 Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient |
| 09/04/2002 | EP0904095B1 Chimeric isoprenoid synthases and uses thereof |
| 09/04/2002 | EP0889878B1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors |
| 09/04/2002 | EP0847397B1 water-soluble c-ring analogues of 20 (s)-camptothecin |
| 09/04/2002 | EP0809636B1 Substituted isoxazoles for the treatment of inflammation |
| 09/04/2002 | EP0781141B1 Aza cyclohexapeptide compounds |
| 09/04/2002 | EP0760664B1 Use of pteridine derivatives as no-synthase inhibitors |
| 09/04/2002 | EP0738107B1 Inhibitors of fatty acid synthesis as antimicrobial agents |
| 09/04/2002 | EP0724587B1 Ring-expanded nucleosides and nucleotides |
| 09/04/2002 | EP0702723B1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 09/04/2002 | EP0682526B1 PULMONARY ADMINISTRATION OF THE SOLUBLE COMPLEM RECEPTOR TYPE 1 sCR1 |
| 09/04/2002 | EP0605680B1 Infectious bovine rhinotracheitis virus mutants and vaccines |
| 09/04/2002 | CN1367834A Proteins derived from white spot syndrome virus and uses thereof |
| 09/04/2002 | CN1367832A Ehrlichia canis genes and vaccines |
| 09/04/2002 | CN1367793A Neuromedin B and somatostatin receptor agonists |
| 09/04/2002 | CN1367792A Somatostatin agonists |
| 09/04/2002 | CN1367790A Moraxella cattarrhalis BASB114 polypeptide antigens and uses thereof |
| 09/04/2002 | CN1367787A Water soluble SDZ-RAD esters |
| 09/04/2002 | CN1367785A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing substituted phenylenediamine group |
| 09/04/2002 | CN1367784A Novel process for preparation of substituted propenone derivatives |
| 09/04/2002 | CN1367780A Oxazolidinones and their preparing method and use thereof |
| 09/04/2002 | CN1367701A Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 09/04/2002 | CN1367693A Pharmaceutical compositions containing poly(ADP-ribose) glycohydrolase inhibitors and method of using the same |
| 09/04/2002 | CN1367683A Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof |
| 09/04/2002 | CN1367256A 2-demethyl 2-methoxy-hygrolidin, its preparation method and medicine composition using said compound as active effective component |
| 09/04/2002 | CN1367180A Novel natural antibacterial peptide, its code sequence and application |
| 09/04/2002 | CN1367169A Substituted 6,6-Hetero-dicycloderivative |
| 09/04/2002 | CN1367021A DNA vaccine for foot-and -mouth disease |
| 09/04/2002 | CN1367018A Compound preparation of staphylococcolysis enzyme and its preparation method and application |
| 09/04/2002 | CN1367014A Medicine for curing foot and mouth disease |
| 09/04/2002 | CN1367011A Medicine for external application for curing dermal viral infection and its preparation method |
| 09/04/2002 | CN1367009A Medicine for curing hepatitis B |
| 09/04/2002 | CN1367007A Medicine for curing common cold |
| 09/04/2002 | CN1367003A Medicine for curing AIDS |
| 09/04/2002 | CN1366997A Liquid medicine for curing beriberi |
| 09/04/2002 | CN1366988A Health-care tea as cigarette companion and its preparation method |
| 09/04/2002 | CN1366980A Compound Chinese herbal medicine for curing tuberculosis |
| 09/04/2002 | CN1366978A Nane common cold-fever-abating preparation medicine and preparation method |
| 09/04/2002 | CN1366965A Nano wind-cold Ganmaoning preparation medicine and preparation method |
| 09/04/2002 | CN1366949A Nano compound formula sarcandra preparation medicine and preparation method |
| 09/04/2002 | CN1366944A Nano common cold-fever-clearing preparation medicine and preparation method |
| 09/04/2002 | CN1366943A Nano bupleurum preparation medicine and preparation method |
| 09/04/2002 | CN1366941A Nano Cuitang preparation medicine and preparation method |
| 09/04/2002 | CN1366940A Nano indigo and clamshell preparation medicine and preparation method |
| 09/04/2002 | CN1366936A Nano antelope lung-clearing preparation medicine and preparation method |
| 09/04/2002 | CN1366935A Nano scourge-clearing toxin-vanquishing preparation medicine and preparation method |
| 09/04/2002 | CN1366907A Nano Jianmin throat-benefiting preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366904A Nano drool-controlling preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366898A Nano jizhi preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366893A Nano qingfei yihuo preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366892A Nano qinghouyan preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366890A Nano clear heat and resolve toxin preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366887A Nano amber dragon-embracing preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366886A Liquor for curing hemorrhagic coliinfection |
| 09/04/2002 | CN1366883A Chitin lozenge and its preparation method |
| 09/04/2002 | CN1366880A Sophorcarpidine alkaloid and decongestant compound medicine and its preparation method |
| 09/04/2002 | CN1090239C Recombinant virus vectors |
| 09/04/2002 | CN1090238C Process for producing enzyme |
| 09/04/2002 | CN1090187C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090186C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090185C Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate thereof |
| 09/04/2002 | CN1090030C Complex cow's milk gamma globulin and making method thereof |
| 09/04/2002 | CN1090029C Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 09/03/2002 | US6444871 Expression vector for use in the treatment and prevention of viral diseases |
| 09/03/2002 | US6444829 (2s,4r)-4-mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid n'-isobutyl-n'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 09/03/2002 | US6444811 Central nervous system disorders; cardiovascular disorders |
| 09/03/2002 | US6444796 Antibiotic; salt formation with formic acid; neutralization |
| 09/03/2002 | US6444790 Peptidoglycan recognition proteins |
| 09/03/2002 | US6444786 Bactericides |
| 09/03/2002 | US6444696 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
| 09/03/2002 | US6444686 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 09/03/2002 | US6444682 Base analogues |
| 09/03/2002 | US6444677 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 09/03/2002 | US6444657 2-(phosphonomethyl)pentanedioic acid; 2-(2-sulfanylethyl) pentanedioic acid; epithelial tissue scarring, collagen vascular disease, fibroproliferation, connective tissue disorder, respiratory distress syndrome; tgf regulator |
| 09/03/2002 | US6444655 Galactopyranosides and their use |
| 09/03/2002 | US6444647 Composition comprising safe and effective amounts of vitamin b3 compound and additional skin care active selected from farnesol and/or phytantriol, and dermatologically acceptable emulsion carrier |